ACE2 and COVID-19: The potential of ACE2/Ang1‐7 to rebalance the severely disrupted renin–angiotensin axis suggests a potential benefit in more severely ill patients with acute respiratory distress syndrome, with or without COVID‐19, where low ACE2 and Ang(1‐7) have been linked to poor prognosis.